Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/7662
Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice
Fuster, Jose J. CNIC | Molina-Sanchez, Pedro CNIC | Jovaní, David | Vinué, Ángela | Serrano, Manuel | Andres, Vicente CNIC
Atherosclerosis. 2012; 221(1):98-105
RATIONALE: Human genome-wide association studies have identified genetic variants in the chromosome 9p21 region that confer increased risk of coronary artery disease and other age-related diseases. These variants are located in a block of high linkage disequilibrium with the neighboring Ink4/Arf tumor-suppressor locus (also named CDKN2A/CDKN2B). Since previous studies suggest an atheroprotective role of the Ink4/Arf locus, here we assessed whether gain-of-function of the encoded genes can be exploited therapeutically to reduce atherosclerosis. METHODS: Generation and characterization of apolipoprotein E-null mice carrying an additional transgenic copy of the entire Ink4/Arf locus (apoE-/-Super-Ink4/Arf) that reproduces the normal expression and regulation of the endogenous locus. RESULTS: Although liver and aorta of apoE-/-Super-Ink4/Arf mice only showed a trend towards increased Ink4/Arf transcript levels compared to apoE-/- controls, cultured macrophages with increased Ink4/Arf gene dosage exhibited augmented apoptosis induced by irradiation with ultraviolet light, indicating that low level of transgene overexpression can lead to augmented Ink4/Arf function. However, increased Ink4/Arf gene dosage did not affect atherosclerosis development in different vascular regions of both male and female apoE-/- mice fed either normal or high-fat diet. Increased gene dosage of Ink4/Arf similarly had no effect on atheroma cell composition or collagen content, an index of plaque stability. CONCLUSION: In contrast with previous studies demonstrating cancer resistance in Super-Ink4/Arf mice carrying an additional transgenic copy of the entire Ink4/Arf locus, our results cast doubt on the potential of Ink4/Arf activation as a strategy for the treatment of atherosclerotic disease.
Animals | Aorta, Thoracic | Aortic Diseases | Apolipoproteins E | Apoptosis | Atherosclerosis | Cell Proliferation | Cells, Cultured | Collagen | Cyclin-Dependent Kinase Inhibitor p15 | Cyclin-Dependent Kinase Inhibitor p16 | Diet, High-Fat | Disease Models, Animal | Female | Hypercholesterolemia | Liver | Macrophages | Male | Mice | Mice, Inbred C57BL | Mice, Knockout | Mice, Transgenic | Ultraviolet Rays | Gene Dosage